Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018

Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today it intends to release its fourth quarter and full year financial results prior to the open of the U.S. financial markets on March 13, 2018. Melinta will host a conference call and live webcast on Tuesday, March 13, 2018 at 8:30am ET to discuss its financial results and provide a business update.